Two investigators (A.P., J.J.B.) independently extracted the following variables from studies: study setting, country, COVID-19 diagnosis, hydroxychloroquine dose and duration, type of control and description, length of stay, primary and secondary outcomes and time of follow up. Discrepancies were resolved through discussion or by a third investigator (A.V.H.).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.